Placental Progesterone Membrane Receptors in Fetal Growth Restriction

Intrauterine growth restriction (IUGR) remains one of the leading causes of perinatal morbidity and mortality. Although placental insufficiency is considered the major underlying mechanism, the molecular pathways responsible for impaired fetal growth are not fully understood.

Progesterone is essential for maintaining pregnancy and exerts its biological effects through both classical nuclear receptors and membrane progesterone receptors. Among these, progesterone receptor membrane component-1 (PGRMC1), progesterone receptor membrane component-2 (PGRMC2), and members of the progestin and adipoQ receptor (PAQR) family have recently attracted attention because of their roles in placental development, angiogenesis, immune regulation, and maintenance of placental integrity.

The present study will prospectively recruit women diagnosed with IUGR and healthy pregnant women delivering at the same institution. Placental samples collected immediately after delivery will undergo molecular analysis using quantitative real-time PCR to determine receptor expression levels. Clinical and obstetric characteristics together with neonatal outcomes will be recorded prospectively.

The findings may contribute to a better understanding of the molecular mechanisms underlying placental dysfunction in IUGR and may identify potential biomarkers associated with adverse pregnancy outcomes.

Inclusion criteria

Singleton pregnancy Maternal age 18-45 years Diagnosis of IUGR according to institutional criteria

Exclusion criteria

Multiple pregnancy Major fetal structural anomaly Chromosomal abnormality Congenital infection Maternal chronic systemic disease Autoimmune disease Chronic hypertension Pregestational diabetes mellitus Placental abruption Intrauterine fetal demise